The Core Body Temperature Rhythms: Distinguishing MCS From UWS
NCT ID: NCT02930213
Last Updated: 2016-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7 participants
OBSERVATIONAL
2015-01-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Heating Transfusion on Brain Function
NCT01930305
Accuracy of Body Temperature Measurements Using the Esophageal Temperature Probe Inserted Through the Gastric Lumen of Supraglottic Airway Device
NCT04485923
Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases
NCT04728438
Comparison Between Non-invasive Heat-flux and Invasive Core Temperature Monitoring
NCT03368040
Continuous Temperature Measurement by Thermal Imaging Camera
NCT06256978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Measuring the continuous external auditory canal temperature of 4 unresponsive wakefulness syndrome (UWS) and 3 minimally conscious state(MCS) on the fluorescent lamp surrounding every 2 hours for 168 hours starting at 00:00 on the first day to address circadian capabilities.
Researchers expected to see the difference between MCS and UWS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with stable condition
* patients free of sedative drugs and Na+ or Ca++ blockers (e.g., carbamazepine) or NMDA receptor antagonist (e.g., dextromethorphan)
Exclusion Criteria
* patients in coma or vegetative state
* patients \< 1 months after the acute brain injury
39 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jing Wang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jing Wang
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CX2014128
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.